MEN1 and gastrin-producing neuroendocrine tumor: This may be particularly true in MEN1 patients suspected of having ZES while taking a PPI, because these patients develop numerous neuroendocrine tumors in numerous locations, which can be positive on SRI, but which are not gastrinomas.